The Effects of ZENECA ZD8731,an Angiotensin II Antagonist,on Renin Expression by Juxtaglomerular Cells in the Rat: Comparison of Protein and mRNA Expression as Detected by Immunohistochemistry and In Situ Hybridization
Free accessResearch articleFirst published online May, 1995
The Effects of ZENECA ZD8731,an Angiotensin II Antagonist,on Renin Expression by Juxtaglomerular Cells in the Rat: Comparison of Protein and mRNA Expression as Detected by Immunohistochemistry and In Situ Hybridization
Changes in the mRNA and protein expression of renin-secreting cells in the juxtaglomerular apparatus (JGA) were examined in the rat following administration of ZENECA ZD8731, an angiotensin II receptor antagonist. Doses of 0 or 90 mg/kg were administered daily by gavage for 26 wk. JGA hypertrophy was apparent in histological sections. Immunohistochemistry demonstrated an increase in the number of renin-containing cells in both the afferent arterioles and the interlobular arteries. Similarly, renin mRNA expression, demonstrated by in situ hybridization, had extended to more proximal segments of the afferent arterioles and was also present in efferent arterioles and interlobular arteries. In conclusion, JGA hypertrophy occurred as a result of antagonism of the angiotensin II receptor. Associated with JGA hypertrophy was increased expression of both renin and renin mRNA, indicative of stimulated renin synthesis caused by an exaggerated pharmacological response of renin-secreting cells to the loss of feedback inhibition by angiotensin II.
Barajas L. (1979). Anatomy of the juxtaglomerular apparatus. Am. J. Physiol. 237: F333-F343.
2.
Doig JK, MacFadyen RJ, Sweet CS, Lees KR, and Reid JL (1993). Dose-ranging study of the angiotensin type I receptor antagonist losartan (DuP753/ MK954) in salt deplete normal man. J. Cardiovasc. Pharmacol. 21: 732-738.
3.
Dominick MA, Bobrowski WF, Metz AL, Gough AW, and MacDonald JR (1990). Ultrastructural juxtaglomerular cell changes in normotensive rats treated with quinapril, an inhibitor of angiotensin-converting enzyme. Toxicol. Pathol. 18: 396-406.
4.
Dzau VJ and Pratt RE (1986). Renin-angiotensin system: Biology, physiology and pharmacology. In: Handbook of Experimental Cardiology, E Haber, H Morgan, A Katz, and H Fozard (eds). Raven Press, New York , pp. D1631-D1661.
5.
Geary KM, Hunt MK, Peach MJ, Gomez RA, and Carey RM (1992). Effects of angiotensin converting enzyme inhibition, sodium depletion, calcium, isoproterenol and angiotensin II on renin secretion by individual renocortical cells. Endocrinology131: 1588-1594.
6.
Gomez RA, Chevalier RL, Everett AD, Elwood JP, Peach MJ, Lynch KR, and Carey RM (1990). Recruitment of renin gene-expressing cells in adult rat kidneys. Am. J. Physiol. 259: F660-F665.
7.
Gomez RA, Chevalier RL, Sturgill BC, Johns DW, Peach MJ, and Carey RM (1986). Maturation of the intrarenal renin distribution in Wistar-Kyoto (WKY) rats. J. Hypertens. 4: S31-S33.
8.
Gomez RA, Lynch KR, Chevalier RL, Everett AD, Johns DW, Wilfong N., Peach MJ, and Carey RM (1988). Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am. J. Physiol. 254: F900-F906.
9.
Hillan KJ (1990). Detection ofmRNA in fixed tissues using RNA probes . In: Nonradioactive Labelling and Detection of Biomolecules , C Kessler (ed). Springer-Verlag , Berlin Heidelberg, pp. 363-367.
10.
Holmer S., Eckardt K-U., Aedtner O., LeHir M., Schricker K., Hamann M., Götz K., Riegger G., Moll W., and Kurtz A. (1993). Which factor mediates renorenal control of renin gene expression?J. Hypertens. 11: 1011-1019.
11.
Johns DW, Peach MJ, Gomez RA, Inagami T., and Carey RM (1990). Angiotensin II regulates renin gene expression . Am. J. Physiol. 259: F882-F887.
12.
Johnson AL, Carini DJ, Chiu AT, Duncia JV, Price WA Jr, Wells GJ, Wexler RR, Wong PC, and Timmermans Pbmwm (1990). Nonpeptide angiotensin II M receptor antagonists. Drug News Perspect3: 337-351.
13.
Ludwig G., Ganten D., Murakami K., Fasching U., and Hackenthal E. (1987). Relationship between renin mRNA and renin secretion in adrenalectomized, salt depleted or converting enzyme inhibitor-treated rats. Mol. Cell. Endocrinol. 50: 223-229.
14.
MacDonald JR , Susick RL Jr, Pegg DG, and Dominick MA (1992). Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor. J. Cardiovasc. Pharmacol. 19: 282-289.
15.
Ménard J., Bouhnik J., Clauser E., Richoux JP, and Corvol P. (1983). Biochemistry and regulation of angiotensinogen . Clin. Exp. Hypertens. Theory Pract. A5(7&8): 1005-1019.
16.
Moe OW, Ujiiek K., Star RA, Miller RT, Widell J., Alpern RJ, and Henrich WL (1993). Renin expression in renal proximal tubule. J. Clin. Invest. 91: 774-779.
17.
Morishita R. , Higaki J., Nagano M., Nakamura F., Tomita N., Zhao Y., Mikami M., and Ogihara T. (1993). Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats. Clin. Exp. Pharmacol. Physiol . 20: 15-20.
18.
Nakamura A. , Iwao H., Fukui K., Kimura S., Tamaki T., Nakanishi S., et al (1990 ). Regulation of liver angiotensin and kidney renin mRNA levels by angiotensin II. Am. J. Physiol. 258: E1-E6.
19.
Nakamura N. , Soubrier F., Menard J., Panthier JJ, Rougeon F., and Corvol P. (1985). Nonproportional changes in plasma renin concentration, renal renin content and rat renin messenger RNA. Hypertension7: 855-859.
20.
Taugner Ch , Poulsen K., Hackenthal E., and Taugner R. (1979). Immunocytochemical localization of renin in mouse kidney. Histochemistry62: 19-27.
21.
Taugner R., Bührle CP, Ganten D., Hackenthal E., Hardegg C., Hardegg G., and Nobiling R. (1983). Immunohistochemistry of the renin-angiotensin-system in the kidney. Clin. Exp. Hypertens. Theory Pract. A5(7&8): 1163-1177.
22.
Taugner R., Hackenthal E., Helmchen U., Ganten D., Kugler P., Marin-Grez M., Nobiling R., Unger T., Lockwald I., and Keilbach R. (1982). The intrarenal renin-angiotensin-system. An immunohistochemical study on the localisation of renin, angiotensinogen converting enzyme and the angiotensins in the kidney of mouse and rat. Klin. Wochenschr . 60: 1218-1222.
23.
Taugner R., Hackenthal E., Rix E., Nobiling R., and Poulsen K. (1982). Immunocytochemistry of the renin-angiotensin system: Renin, angiotensinogen, angiotensin I, angiotensin II and converting enzyme in the kidneys of mice, rats and tree shrews. Kidney Int. 22:S33-S43.
24.
Timmermans Pbmwm , Wong PC, Chiu AT, and Herblin WF (1991). Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol. Sci. 12: 55-62.
25.
Tree M., Brown JJ, Leckie BJ, Lever AF, Manheim P., Morton JJ, Robertson JIS, Szelke M., and Webb D. (1984). Renin and blood pressure. Biochem. Soc. Trans. 1: 948-951.
26.
Xie M-H. , Liu F-Y., Wong PC, Timmermans PBMWM , and Cogan MG (1990). Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist . Kidney Int . 38: 473-479.
27.
Zaki FG, Keim GR, Takii Y., and Inagami T. (1982). Hyperplasia of juxtaglomerular cells and renin localization in kidneys of normotensive animals given captopril. Ann. Clin. Lab. Sci. 12: 200-215.
